Literature DB >> 22766796

Regulators of skeletal development: a cluster analysis of 206 bone tumors reveals diagnostically useful markers.

Andrew E Horvai1, Ritu Roy, Dariusz Borys, Richard J O'Donnell.   

Abstract

The molecules Indian hedgehog (IHH), SP7 (also known as osterix), sex-determining region Y-box 9 (SOX9), runt-related transcription factor 2 (RUNX2) and TWIST1 regulate the normal differentiation of osteo- and chondrogenic cells from precursors during skeletal development and remodeling. The aberrant function of the same molecules has been implicated in the pathogenesis of bone tumors. Preliminary studies suggest that antibodies against these molecules have practical, diagnostic or prognostic utility in tumors. However, a comprehensive analysis of the expression of these molecules in a large, diverse set of bone tumors has yet to be reported. The goals of this study were to compare the immunohistochemical profiles of IHH, SP7, SOX9, RUNX2 and TWIST1 among bone tumors and to determine the optimum panel for diagnostic utility. Tissue microarrays prepared from 206 undecalcified tumors (71 osteosarcomas, 26 osteoblastomas/osteoid osteomas, 50 giant cell tumors, 5 chondromyxoid fibromas and 54 chondroblastomas) were stained with antibodies to IHH, SP7, SOX9, RUNX2 and TWIST1. The stains were scored for intensity (0-3+) and distribution. The results were analyzed by cluster analysis. Optimum antibody panels for diagnostic sensitivity and specificity were calculated. Analysis revealed six main clusters that corresponded well to tumor types and suggested a close relationship between the stromal cells of giant cell tumor and the osteoblasts of osteosarcoma. The expression profile of chondromyxoid fibroma and chondroblastoma also suggested related differentiation. The distribution of osteoblastomas and osteoid osteomas was more heterogeneous. RUNX2, SOX9 and TWIST1 represented the most sensitive and specific immunohistochemical panel to distinguish among these diagnoses with the limitation that no result could discriminate between chondroblastoma and chondromyxoid fibroma. IHH and SP7 did not yield additional utility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22766796     DOI: 10.1038/modpathol.2012.110

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  9 in total

Review 1.  Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer.

Authors:  Mousumi Tania; Md Asaduzzaman Khan; Junjiang Fu
Journal:  Tumour Biol       Date:  2014-06-02

Review 2.  EMT transcription factors: implication in osteosarcoma.

Authors:  Guoqiong Yang; Jian Yuan; Kanghua Li
Journal:  Med Oncol       Date:  2013-08-24       Impact factor: 3.064

3.  Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone.

Authors:  Peter Balla; Mate Elod Maros; Gabor Barna; Imre Antal; Gergo Papp; Zoltan Sapi; Nicholas Anthony Athanasou; Maria Serena Benassi; Pierro Picci; Tibor Krenacs
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

4.  Evaluation of canonical Hedgehog signaling pathway inhibition in canine osteosarcoma.

Authors:  Vincent E Baldanza; Anita Rogic; Weiwei Yan; Corri B Levine; Roy A Levine; Andrew D Miller; Angela L McCleary-Wheeler
Journal:  PLoS One       Date:  2020-04-29       Impact factor: 3.240

5.  Special AT-rich sequence-binding protein 2 (SATB2) in the differential diagnosis of osteogenic and non-osteogenic bone and soft tissue tumors.

Authors:  Sharon Milton; Anne Jennifer Prabhu; V T K Titus; Rikki John; Selvamani Backianathan; Vrisha Madhuri
Journal:  J Pathol Transl Med       Date:  2022-09-13

6.  Expression and significance of c-kit and epithelial-mesenchymal transition (EMT) molecules in thymic epithelial tumors (TETs).

Authors:  Zhigang Wu; Songtao Xue; Bin Zheng; Rongjin Ye; Guobing Xu; Shuliang Zhang; Taidui Zeng; Wei Zheng; Chun Chen
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

7.  SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis.

Authors:  Branden A Smeester; Nicholas J Slipek; Emily J Pomeroy; Heather E Bomberger; Ghaidan A Shamsan; Joseph J Peterson; Margaret R Crosby; Garrett M Draper; Kelsie L Becklin; Eric P Rahrmann; James B McCarthy; David J Odde; David K Wood; David A Largaespada; Branden S Moriarity
Journal:  Oncogene       Date:  2019-10-03       Impact factor: 9.867

Review 8.  Hedgehog signalling in the tumourigenesis and metastasis of osteosarcoma, and its potential value in the clinical therapy of osteosarcoma.

Authors:  Zhihong Yao; Lei Han; Yongbin Chen; Fei He; Bin Sun; Santosh Kamar; Ya Zhang; Yihao Yang; Cao Wang; Zuozhang Yang
Journal:  Cell Death Dis       Date:  2018-06-13       Impact factor: 8.469

9.  Identification of Biomarkers for Osteosarcoma Based on Integration Strategy.

Authors:  Junjie Bao; Zhaona Song; Chunyu Song; Yahui Wang; Wan Li; Wei Mai; Qingyu Shi; Hongwei Yu; Linying Ni; Yishu Liu; Xiaolin Lu; Chuan He; Lina Chen; Guofan Qu
Journal:  Med Sci Monit       Date:  2020-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.